share_log

Canaccord Genuity Reiterates Buy on Axogen, Maintains $11 Price Target

Benzinga ·  Dec 7, 2023 10:44

Canaccord Genuity analyst Caitlin Cronin reiterates Axogen (NASDAQ:AXGN) with a Buy and maintains $11 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment